logo

For the Inventor, By the Inventor

Monza, Italy

Luigi A Rovati

This inventor holds 27 USPTO granted patents, primarily in Pharmaceutical Formulations. Top assignees: Rotta Research Laboratorium, Rotta Research Laborarorium S.p.a., Rotta Research Laboratories S.p.a.. Active years: 1976-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luigi A Rovati. Retrieved from https://idiyas.com/inventor/luigi-a-rovati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27

% Patents Active = 92.6

Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 207(Granted Patents)


Location History:

  • San Fruttuoso di Monza (Milan), IT (1976 - 1977)
  • S. Fruttuoso di Monza, IT (1981)
  • San Fruttuoso di Monza, IT (1981 - 1987)
  • Milano, IT (1990)
  • Brescia, IT (2004)
  • 41100 Modean, IT (2008)
  • Monza, IT (1986 - 2017)

Company Filing History:

goldMedal22 out of 33 
 
Rotta Research Laboratorium
 patents
silverMedal1 out of 1 
 
Rotta Research Laborarorium S.p.a.
 patent
bronzeMedal1 out of 2 
 
Rotta Research Laboratories S.p.a.
 patents
4. 1 out of 26 
 
Rottapharm Spa
 patents
5. 2 out of 834,453 
Other
 patents

Years Active: 1976-2017

Loading Chart...
Areas of Expertise:
Cardiovascular System
Blood Glucose Measurement
Antigastrin Activity
Oral Administration
Acrylic-Based Matrix
Optically-Active Derivatives
Quinazoline Derivatives
Glutamic Acid Derivatives
Stable Compounds
Anti-Inflammatory Compounds
Pharmaceutical Preparations
Laser Therapy
27 patents (USPTO):Explore Patents
1. 9623108 - Formulation for oral administration with beneficial effects on the cardiovascular system (2017-04-18),
2. 7465299 - Monitoring of retinal temperature during laser therapy (2008-12-16),
3. 6704588 - Method and apparatus for the non-invasive measurement of blood glucose levels in humans (2004-03-09),
4. 6156335 - Preparation with an acrylic-based, adhesive copolymeric matrix for the (2000-12-05),
5. 6075033 - Anthranilic acid diamides derivatives, their preparation and (2000-06-13),
6. 5985885 - Quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having (1999-11-16),
7. 5962502 - Polyamidic acid derivatives with antigastrin activity, a method for (1999-10-05),
8. 5922875 - Aromatic acid diamides with antigastrin activity, a method for their (1999-07-13),
9. 5744607 - Basic derivatives of glutamic acid and aspartic acid as gastrin or (1998-04-28),
10. 5723494 - Derivatives of glutamic and aspartic acids, a method of preparing them, (1998-03-03),
11. 5602179 - Optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid (1997-02-11),
12. 5587479 - Basic derivatives of glutamic acid and aspartic acid as gastrin or (1996-12-24),
13. 5500430 - Amidic derivatives of glutamic, aspartic and 2-amino adipic acids, a (1996-03-19),
14. 5391574 - Optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid (1995-02-21),
15. 5130474 - Optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid (1992-07-14),

Title: Luigi A Rovati: Innovator in Cardiovascular Formulations

Introduction: Luigi A Rovati is an esteemed inventor located in Monza, Italy, with a remarkable portfolio of 25 patents. His contributions to the field of pharmaceutical formulations, particularly those designed to benefit the cardiovascular system, underline his expertise and innovative spirit.

Latest Patents: Among his most recent patents is a formulation for oral administration designed to exert beneficial effects on the cardiovascular system. This formulation, presented in the form of tablets or powder for extemporaneous use, demonstrates eulipidaemic activity, cholesterol-lowering and triglyceride-lowering effects, as well as antioxidant properties. It comprises berberine in combination with policosanol and/or red yeast, and it preferably contains antioxidants such as astaxanthin and/or folic acid. Additionally, he has developed a preparation utilizing an acrylic-based, adhesive copolymeric matrix, showcasing his commitment to advancing healthcare solutions.

Career Highlights: Luigi has made significant strides in the pharmaceutical industry through his work, notably with companies such as Rotta Research Laboratorium S.p.a. and Rotta Research Laboratories S.p.a. His dedication to research and innovation has solidified his reputation as a leader in his field.

Collaborations: Throughout his career, Luigi has collaborated with notable individuals such as Francesco Makovec and Walter Peris. These partnerships have facilitated the development of innovative solutions and have further enhanced his contributions to the industry.

Conclusion: Luigi A Rovati stands out as an influential inventor whose work in cardiovascular formulations has the potential to make a significant impact on health and wellness. His 25 patents reflect a deep commitment to innovation, showcasing his ability to address complex medical challenges through creativity and scientific expertise.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…